Skip to content
OpenCapital
Earnings
Screener
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Relmada Therapeutics, Inc.
Business Segments
Income Statement
Balance Sheet
Cash Flow
Segments
Relmada Therapeutics, Inc. Business Segments
Business, geographic, and product segment breakdowns
Market Cap
$683.9M
No metrics found for this filter.
